Schonfeld Strategic Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-64,850
| Closed | -$480K | – | 2195 |
|
|
2024
Q4 | $480K | Sell |
64,850
-330,597
| -84% | -$2.45M | ﹤0.01% | 1364 |
|
|
2024
Q3 | $3.71M | Buy |
+395,447
| New | +$3.71M | 0.02% | 535 |
|
|
2024
Q2 | – | Sell |
-244,447
| Closed | -$3.62M | – | 2161 |
|
|
2024
Q1 | $3.62M | Sell |
244,447
-777,371
| -76% | -$11.5M | 0.02% | 631 |
|
|
2023
Q4 | $8.31M | Buy |
+1,021,818
| New | +$8.31M | 0.06% | 369 |
|
|
2023
Q3 | – | Sell |
-36,751
| Closed | -$259K | – | 1847 |
|
|
2023
Q2 | $259K | Sell |
36,751
-265,767
| -88% | -$1.87M | ﹤0.01% | 1397 |
|
|
2023
Q1 | $1.85M | Sell |
302,518
-695,582
| -70% | -$4.25M | 0.02% | 706 |
|
|
2022
Q4 | $6.38M | Buy |
998,100
+824,917
| +476% | +$5.27M | 0.05% | 413 |
|
|
2022
Q3 | $1.66M | Buy |
+173,183
| New | +$1.66M | 0.01% | 962 |
|
|
2021
Q4 | – | Sell |
-91,641
| Closed | -$2.26M | – | 2151 |
|
|
2021
Q3 | $2.26M | Buy |
91,641
+82,441
| +896% | +$2.03M | 0.02% | 620 |
|
|
2021
Q2 | $239K | Sell |
9,200
-20,301
| -69% | -$527K | ﹤0.01% | 1542 |
|
|
2021
Q1 | $935K | Buy |
29,501
+21,169
| +254% | +$671K | 0.01% | 887 |
|
|
2020
Q4 | $387K | Sell |
8,332
-42,637
| -84% | -$1.98M | 0.01% | 1081 |
|
|
2020
Q3 | $1.68M | Buy |
50,969
+7,610
| +18% | +$251K | 0.03% | 525 |
|
|
2020
Q2 | $1.19M | Buy |
43,359
+31,224
| +257% | +$857K | 0.03% | 528 |
|
|
2020
Q1 | $363K | Sell |
12,135
-214,716
| -95% | -$6.42M | 0.02% | 683 |
|
|
2019
Q4 | $6.28M | Buy |
226,851
+84,251
| +59% | +$2.33M | 0.15% | 163 |
|
|
2019
Q3 | $2.6M | Buy |
142,600
+122,800
| +620% | +$2.24M | 0.08% | 268 |
|
|
2019
Q2 | $485K | Sell |
19,800
-168,630
| -89% | -$4.13M | 0.02% | 639 |
|
|
2019
Q1 | $1.79M | Sell |
188,430
-749,870
| -80% | -$7.14M | 0.06% | 370 |
|
|
2018
Q4 | $8.3M | Buy |
+938,300
| New | +$8.3M | 0.32% | 74 |
|
|
2018
Q2 | – | Sell |
-29,541
| Closed | -$499K | – | 839 |
|
|
2018
Q1 | $499K | Buy |
+29,541
| New | +$499K | 0.04% | 476 |
|
|
2017
Q3 | – | Sell |
-34,024
| Closed | -$250K | – | 658 |
|
|
2017
Q2 | $250K | Buy |
+34,024
| New | +$250K | 0.03% | 516 |
|